Brief: Moberg Pharma's MOB-015 Gets Market Authorisation In Ireland

Moberg Pharma AB (publ)

31/07/2023 12:24

July 31 (Reuters) - Moberg Pharma  MBPH.ST :
    * NATIONAL APPROVAL FOR MOB-015 IN IRELAND
    * IRELAND IS FIRST COUNTRY TO GRANT MARKET AUTHORIZATION FOR
MOBERG PHARMA'S NEW ONYCHOMYCOSIS TREATMENT AFTER DECENTRALIZED
PROCEDURE CONCLUDED WITH A POSITIVE OUTCOME
    * NATIONAL APPROVALS ARE EXPECTED TO FOLLOW DURING UPCOMING
MONTHS
AND TIMELINES MAY VARY BETWEEN COUNTRIES

Source text for Eikon:  ID:nWkr2kCHv5 
Further company coverage:  MBPH.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;  +48 58 769 66 00;))